Covestro medical-grade Makrolon polycarbonate has been used for a wound healing device developed by Vaporox.
Covestro
Vaporox’s Vaporous Hyperoxia Therapy (VHT) technology is clinically validated for healing skin wounds and a combination of Covestro resin and technical support helps bring next-generation wound care medical device to market.
Chronic wounds afflict millions of people. If not treated adequately, they can lead to severe complications, including amputation of limbs. Denver-based Vaporox developed a medical device for healing chronic wounds that do not respond to conventional wound treatment. The vaporiser component of the medical device primarily uses Makrolon 2458 polycarbonate from Covestro.
The VHT-200 (Vaporous Hyperoxia Therapy) system, which received U.S. Food and Drug Administration (FDA) clearance, features a unique combination of elements that accelerate healing—ultrasonic vapor and concentrated oxygen. According to Vaporox, the patented delivery system for these elements promotes revascularisation and tissue growth. The treatment is intended for administration in clinics and physicians’ offices.
Chase Huskey, marketing manager, Vaporox, said: “Vaporox is committed to a world where all wounds heal. Today, wound care is one of the most under-served markets in the medical industry, but this development is truly life-changing for patients and a huge step forward for this market.”
Covestro was involved throughout the device’s development, supplying prototype quantities of its material, and documentation required by the FDA.
Makrolon 2458 polycarbonate is a low-viscosity, injection-moulding medical grade that features easy release from the mould. It is suitable for Ethylene Oxide (EtO) and steam sterilisation and is biocompatible according to many ISO 10993-1 test requirements. It is available in transparent and opaque options.
Mark Nichols, healthcare key account manager, Covestro, added: “For decades, the healthcare market has relied on our proven portfolio of medical grade Makrolon polycarbonates, complemented by customized technical expertise. Our work with Vaporox demonstrates the value of collaboration as our customers develop and bring truly innovative, game-changing technology to market.”
